BioProcessing Summit
Tell a Friend About This EventTell a Friend
BioProcessing Summit

8/13/2019 to 8/15/2019
When: August 14
Where: Seaport World Trade Center
Boston, Massachusetts 
United States

« Go to Upcoming Event List  

Join the ISCT Process and Product Development Subcommittee on Wednesday, August 14 from 10:45-12:45 at the Bioprocessing Summit for a Special Event Session: Translating Science to Medicine: How Cell Therapy Developers Must Overcome Challenges to Plan for Commercial Success.

ISCT members are eligible for 20% off registration for The Bioprocessing Summit using discount code ISCT20 (must be entered at registration checkout) . *This offer is valid for new registrants only, does not apply to previously registered attendees, and cannot be combined with any other offer. Register Now.

SESSION DETAILS - View complete overview on the Bioprocessing Summit website

The ISCT Process and Product Development (PPD) Subcommittee strives to be the leading source of educational content for overcoming global challenges in translating cell and gene therapeutics from the bench to the bedside. Developing a cell and gene therapy process and translating that process to a scalable manufacturing platform for clinical and commercial success requires a multifaceted approach. Through industry feedback, the members of the PPD have been actively collaborating and addressing translational requirements to drive the industry forward.

This session will highlight critical considerations for overcoming challenges from an end to end development perspective. A sequence of short presentations will be followed by an open and interactive discussion.

Session and ISCT PPD Subcommittee Co-Chairs:

Dominic Clarke, PhD, Global Head of Cell Therapy, HemaCare, USA

John Fink, MBA, Product Manager, Cellular, Pall Corporation, USA

 

ISCT Cost of Goods Survey – Learnings

John Fink, MBA, Product Manager, Cellular, Pall Corporation, USA

 

End to End:  A Manufacturing Overview

David Smith, PhD, Head of Innovation and Engineering, Hitachi Advanced Therapeutics Solutions, USA

 

Cell Culture Scalability and Flexibility

Shannon Eaker, PhD, Cell Therapy Enterprise Technical Leader, GE Healthcare, USA

 

Freezing, Storage and Transit – Biopreservation Best Practices

Alireza Abazari, PhD, Senior Scientist, Process Development, Lyell Immunopharma, USA

 

Automation – What, When, How

Ohad Karnieli, PhD, MBA, CEO & Co-Founder, Atvio Biotech, Israel

 

A Developer’s Perspective

Yonatan Lipsitz, PhD, Team Lead - Cell Therapy Process Development, Sana Biotechnology, USA

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy